|Safety Alerts and Recalls – MPR|
|Recall: Small Amounts of Asbestos Identified in Baby Powder|
|Fri, 18 Oct 2019 19:07:42 +0000|
Johnson & Johnson Consumer announced the voluntary recall of Lot #22318RB of Johnson’s Baby Powder due to the presence of sub-trace levels of chrysotile asbestos contamination.
The post Recall: Small Amounts of Asbestos Identified in Baby Powder appeared first on MPR.
|FDA: Stop Using Vaping Products Containing THC|
|Mon, 07 Oct 2019 14:01:41 +0000|
An updated alert from the Food and Drug Administration is warning consumers to stop using e-cigarettes or vapes.
|CVS Suspends Sale of Zantac, OTC Generic as More Ranitidine Recalls Announced|
|Tue, 01 Oct 2019 16:22:39 +0000|
The Food and Drug Administration (FDA) is alerting healthcare professionals and patients of a voluntary recall of over-the-counter (OTC) ranitidine tablets 75mg and 150mg (all pack sizes and formats) manufactured by Apotex Corp. and labeled by Walgreens, Walmart, and Rite-Aid due to the presence of the probable human carcinogen, N-nitrosodimethylamine (NDMA), at low levels. Additionally,…
The post CVS Suspends Sale of Zantac, OTC Generic as More Ranitidine Recalls Announced appeared first on MPR.
|Ranitidine Recall Issued Following Discovery of NDMA|
|Tue, 24 Sep 2019 18:16:03 +0000|
At this time, the Company has not received any adverse event reports related to use of the recalled product.
The post Ranitidine Recall Issued Following Discovery of NDMA appeared first on MPR.
|Maker Halts Distribution of Generic Zantac Due to Possible Carcinogen|
|Fri, 20 Sep 2019 12:15:10 +0000|
Preliminary tests revealed low levels of the nitrosamine impurity NDMA in some ranitidine products
The post Maker Halts Distribution of Generic Zantac Due to Possible Carcinogen appeared first on MPR.
|FDA: Nitrosamine Impurity Identified in Commonly Used Acid Suppressant|
|Fri, 13 Sep 2019 17:35:05 +0000|
According to the Food and Drug Administration (FDA), a nitrosamine impurity, N-nitrosodimethylamine (NDMA), has been identified in some samples of ranitidine. NDMA was one of several nitrosamine impurities implicated in the massive recall of angiotensin II receptor blockers (ARBs) since last year. NDMA is classified as a probable human carcinogen; the impurity was identified following…
The post FDA: Nitrosamine Impurity Identified in Commonly Used Acid Suppressant appeared first on MPR.
|Recall of All Doses of Parathyroid Hormone Natpara Issued|
|Fri, 06 Sep 2019 16:47:54 +0000|
Takeda announced a voluntary recall of all doses of Natpara (parathyroid hormone) injection (25mcg, 50mcg, 75mcg, 100mcg) due to the possible presence of small rubber particulates in the Natpara cartridge originating from the rubber septum. Takeda is notifying healthcare professionals, patients, and specialty pharmacies regarding the recall. Natpara is supplied as a multiple-dose, dual-chamber glass…
The post Recall of All Doses of Parathyroid Hormone Natpara Issued appeared first on MPR.
|Cancer Risk From Recalled ARBs “Likely Much Lower” Than Initially Estimated, Says FDA|
|Tue, 03 Sep 2019 16:51:08 +0000|
The Food and Drug Administration (FDA) is taking necessary actions, including regulatory and advisory actions, to prevent the presence of nitrosamine impurities in angiotensin II receptor blockers (ARB) following recent recalls that have raised concerns among patients, the medical community, the FDA and international regulatory bodies. In a press statement, the FDA clarified that the…
The post Cancer Risk From Recalled ARBs “Likely Much Lower” Than Initially Estimated, Says FDA appeared first on MPR.
|CDC Issues Warning About Cases of Severe Pulmonary Disease Linked to E-Cigarette Use|
|Tue, 03 Sep 2019 15:23:20 +0000|
The use of e-cigarette products has been associated with several cases of severe pulmonary disease, according to the Centers for Disease Control and Prevention (CDC). In an official health advisory, the CDC stated that 215 possible cases have been reported across 25 states, with additional suspected cases still under investigation. One death has also been…
The post CDC Issues Warning About Cases of Severe Pulmonary Disease Linked to E-Cigarette Use appeared first on MPR.
|Losartan, Ezetimibe Recall Initiated Due to Bottles Not Being Child Resistant|
|Fri, 30 Aug 2019 16:30:18 +0000|
Sandoz announced a voluntary recall of certain lots of Losartan Potassium and Ezetimibe prescription bottles due to not meeting federal standards for child-resistant packaging as required by the Poison Prevention Packaging Act.
The post Losartan, Ezetimibe Recall Initiated Due to Bottles Not Being Child Resistant appeared first on MPR.